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Background: Primary diffuse leptomeningeal gliomatosis (PDLG) is a lethal neoplasm that is characterized by
glioma cells exclusively infiltrating into cerebral and spinal meninges. Intraventricular hemorrhage as an initial
symptom in PDLG patient has not been reported in the literatures.
Case presentation: A 39-year-old man initially presented with intraventricular hemorrhage. The patient had an
improved outcome at the early stage of hemorrhagic course; however, the clinical condition began to a sudden
turn for deterioration with intracranial hypertension and cerebral hernia on day 15 after admission. Cerebral CT and
MRI showed diffuse patchy signals with enhancement in bilateral cerebellopontine angle cistern, suprasellar cistern,
ambient cistern, quadrigeminal cistern, bilateral cerebellum, cerebral hemisphere, and upper cervical cord surface.
Pathological examination revealed that numerous spindled cells were scant of cytoplasm with hyperchromatic
nuclei and various mitotic figures. Immunohistochemistry showed that the cells were positive to glial fibrillary acidic
protein (GFAP) with about 5 % Ki-67 positive labeling. The pathological findings were consistent with the diagnostic
criteria of anaplastic astrocytoma (WHO grade III).
Conclusion: We reported an interesting case that PDLG initially presented with intraventricular hemorrhage that
might be caused by astrocytoma rupturing into pial vessels.
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Primary diffuse leptomeningeal gliomatosis (PDLG) is a
lethal neoplasm that is characterized by glioma cells dif-
fusely infiltrating into cerebral and spinal meninges,
while absent of tumorous lesions in the brain paren-
chyma [1–3]. Non-specifically insidious headache is the
most common initial symptom in patients with PDLG
[4]. Laboratory investigations and radiological examina-
tions are absent of characteristic features for the diagno-
sis of PDLG. Therefore, it is difficult to make a definitive
diagnosis during the patient’s survival time [5]. Up to date,
there are about 50 cases of PDLG having been reported in
literatures, and more than half of patients are made a de-
finitive diagnosis through postmortem [2, 6, 7].* Correspondence: hongdaojun@hotmail.com
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creativecommons.org/publicdomain/zero/1.0/In a cohort of study, 4.9 % patients discharged with diag-
nosis as brain neoplasm were initially considered as a stroke
[8]. About 5 % patients with gliomas would have stroke-like
hemorrhage [9]. Generally, patients with tumor-related
cerebral hemorrhage usually have an obvious parenchymal
lesion in the brain [10]. However, no patients with PDLG
initially presenting with intraventricular hemorrhage have
been reported in the literatures. Herein, we described a case
of 39-year-old man initially presented with intraventricular
hemorrhage, finally was diagnosed as PDLG associated with
anaplastic astrocytoma.
Case presentation
The patient was a 39-year-old man who was diagnosed
as tuberculous pleurisy at age 30, and then was treated
with standard anti-tubercular drugs for 6 months, but
clinical follow-up was not carried out after alleviation of
his symptoms. No history of hypertension was recorded.
He had nonspecific headache one month ago, but nole distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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with right paresis, headache and vomiting for one hour.
On admission, his blood pressure was 130/80 mmHg.
He had slightly slurred pronunciation; muscle strength
was 4/5 grade (MRCS, grades 0–5) in the right limbs;
and slight hearing loss was found on the right side. Neck
stiffness and Kerning sign were also observed. Cerebral
computed tomography (CT) revealed hemorrhage in the
left posterior horn of lateral ventricle and subarachnoid
space (Fig. 1a). At the same time, a nodular mass with
slightly high density was observed at the right ventral
surface of the pons (Fig. 1b). After treatments for decreas-
ing intracranial pressure by mannitol and anti-vasospasm
by nimodipine for 10 days, the patient felt great alleviation
of headache. CT scan showed hemorrhage almost disap-
peared (Fig. 1c), but the nodular mass still was unchanged
(Fig. 1d). Cerebral CT angiography underwent on day 2
after admission revealed no aneurysm and vascular mal-
formation, but there were obvious enhancement of lesions
at the right ventral surface of the pons, right temporal tip,
and tentorium of cerebellum (Additional file 1: Figure S1).
However, on day 15 after admission, he suddenly suf-
fered from severe headache and recurrent vomiting. No
fever and bellyache was observed. To exclude the possibil-
ity of rehemorrhage, cerebral CT was performed again.
No hematoma was found (Fig. 1e), but the nodular mass
became more prominent accompanying abnormal density
in the tentorium of cerebellum (Fig. 1f). CerebralFig. 1 The dynamic change of cerebral CT after cerebral hemorrhage. At th
ventricle (a, arrow), and a nodular mass with slightly high density at the rig
showed hemorrhage almost disappeared (c), but the nodular mass still was u
completely absorbed (e), but the nodular mass became more prominent accomagnetic resonance imaging (MRI) revealed multiple ab-
normal patchy signals with marked enhancement distrib-
uting in bilateral cerebellopontine angle cistern (Fig. 2a,
b), suprasellar cistern, ambient cistern, quadrigeminal cis-
tern (Fig. 2c), bilateral cerebellum (Fig. 2d), cerebral hemi-
sphere (Fig. 2e), and upper cervical cord surface (Fig. 2f).
Susceptibility weighted imaging (SWI) showed the
hemorrhagic lesion located at the in-depth of left calcarine
fissure (Fig. 2g), which was confirmed by the axial (Fig. 2h)
and coronal (Fig. 2i) enhanced MR imaging. Magnetic res-
onance spectroscopy revealed that the peak of N-
acetylaspartate decreased, while the peak of choline was
significantly elevated. Based on the clinical features and
radiological changes, several possible diseases such as
tuberculous meningitis, fungal infections, meningeal
neoplasm, metastases, and vasculitis were taken into
consideration. So a series of examinations were further
carried out. Cerebrospinal fluid (CSF) examination re-
vealed that the number of the nucleated cells was 4 cell/
ul; glucose level was 3.5 mmol/L (concomitant blood
glucose 4.7 mmol/L); chlorine level was 115 mmol/L;
and protein level was 2343 mg/L. Additional CSF exam-
inations including latex agglutination test, ink stain, and
modified acid fast staining were negative. Many neutro-
phils without malignant cells were observed in CSF cy-
tology. No neoplasm was found by thoracoabdominal
CT. Positron emission tomography (PET) scan showed
an increased uptake in the right parietal lobe, left frontale first day, CT revealed hemorrhage in the left posterior horn of lateral
ht ventral surface of the pons (b, arrow). At the 10th day, CT scan
nchanged (d, arrow). At the 15th day, CT showed hematoma was
mpanying abnormal density in the tentorium of cerebellum (f, arrow)
Fig. 2 The features of cerebral MRI. MRI showed multiple abnormal patchy signals with marked enhancement in bilateral cerebellopontine angle
cistern (a, b, arrow), quadrigeminal cistern (c, arrow), bilateral cerebellum (d, arrow), cerebral hemisphere (e, arrow), and upper cervical cord surface
(f, arrow). SWI showed the hemorrhagic lesion located at the in-depth of left calcarine fissure (g, arrow), which was confirmed by the axial (h, arrow)
and coronal (i, arrow) enhanced MR imaging
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boratory examinations revealed serum tumor bio-
markers (AFP, CEA, CA199, CA125, CA153, CA724,
PSA, NSE and Cyfra21-1), blood routine, thyroid func-
tion, extractable nuclear antigen polypeptide spectrum,
and anti-neutrophil cytoplasmic antibody were normal.
T-spot test was positive. After tuberculous meningo-
encephalitis and fungal infections were excluded, intra-
venous dexamethasone (20 mg for 7 days and then
10 mg for 3 days) was started on day 20 after admission,
but no clinical improvement was observed.
On day 36 after admission, second CSF examination
was performed. Results showed nucleated cells count
was 8 cells/uL; glucose level was 3.39 mmol/L (concomi-
tant blood glucose 5.37 mmol/L); chlorine level was
116 mmol/L; and protein level was 1787 mg/L. Malig-
nant cells also were not found in cytology. His situation
showed no signs of improvement and graduallyworsened daily. After a written consent signed by pa-
tient’s wife, a needle biopsy of the lesion in the left
frontal lobe was performed on day 46 after admission.
On day 3 after biopsy, he died from cerebral hernia
owing to intractable intracranial hypertension.
Pathological examination revealed that numerous
spindled cells were scant of cytoplasm with hyperchro-
matic nuclei and various mitotic figures (Fig. 3a, b).
Necrosis and vascular endothelial proliferation were
not observed. Immunohistochemistry showed that the
tumor cells were positive to glial fibrillary acidic pro-
tein (GFAP) (Fig. 3c) and S-100 protein. The timorous
lesion was negative to CD34, epithelial membrane anti-
gen, progesterone receptor, and vimentin. Ki-67 label-
ing indicated about 5 % index of proliferation (Fig. 3d).
The pathological findings were consistent with the
diagnostic criteria of anaplastic astrocytoma (WHO
grade III).
Fig. 3 The Pathological changes of the lesion at the bottom of right frontal lobe. Hematoxylin eosin (HE) stain revealed numerous tumor cells were
scant of cytoplasm with hyperchromatic nuclei and various mitotic figures (a, bar=50um), high magnification (b, bar=10um). Immunohistochemistry
showed tumor cells were positive to glial fibrillary acidic protein (GFAP) (c, bar=10um). Ki-67 labeling indicated about 5 % index of proliferation
(d, bar=50um)
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Leptomeningeal gliomatosis is usually divided into sec-
ondary type and primary type [11]. The secondary type
is caused by metastasis of glioma originated in the brain
parenchyma; however, the primary type may arise from
heterotopic glial cell nests in the pial surface of the brain
and spinal cord, which can be found throughout the
neuroaxis [12]. Prior to high resolution imaging, the de-
finitive diagnosis of PDLG was dependent on autopsy to
rule out a primary parenchymal source for the lepto-
meningeal seeding [6, 7, 13]. With the advent of im-
proved imaging techniques, the diagnosis of PDLG is
becoming more common and can be legitimately consid-
ered during the patient’s survive time, especially based
on the gadolinium-enhanced MRI and biopsy [14, 15].
Cerebral MRI in our patient revealed diffuse, nodular
leptomeningeal enhancement around the surface of
brainstem, cerebellum, cerebrum, and upper cervical
cord, while absent of distinct parenchymal lesions on the
MR imaging. Ultimately, the diagnosis of PDLG was
established on the pathological results.
The most interesting clinical feature was intracranial
hemorrhage as the initial symptom in this PDLG patient.
Burrus TM et al. in 2009 described a case diagnosed as
hemorrhagic glioblastoma of the frontal lobe adherent to
the underlying dura with leptomeningeal metastases [16].
However, intraventricular hemorrhage was first described
in our patient with diffuse leptomeningeal lesions. The
natural history of PDLG contains two stages includingchronic prodromal phase and acute neurological deficits
[1–3]. The main clinical manifestations may include head-
ache, papilledema, cranial never paralysis, seizure, back
pain, paresthesia, decreased mental status, and visual im-
pairment, which are nonspecific and difficult to make a
definite diagnosis at the early stage [4, 15]. As for this pa-
tient, we initially made a misdiagnosis as simple cere-
bral hemorrhage after ruling out aneurysm and vascular
malformation. In fact, the clinical condition of this pa-
tient was gradually improved in accordance with the
outcome of cerebral hemorrhage during the first stage
of clinical course. However, the patient’s condition sud-
denly became worse when the ruptured blood completely
disappeared. The clinical shift, rapid aggressiveness, and
short course of this disease were completely beyond our
expectations. It still needs to further discuss whether
intracranial hemorrhage can promote the dissemination
and tumor seeding of leptomeningeal gliomatosis.
The most important features of PDLG in radiological
images are exclusive lesions in pia mater, which are
prone to involving in posterior fossa, basilar cistern and
spinal cord [14, 15]. Cerebral MRI in our case showed
multiple nodular lesions in brain and upper cervical cord
indicating the tumor widely distributing in CNS, which
was conformed to the diffuse type of PDLG [17]. Many
of the cases reported as PDLG are complicated by focal
parenchymal involvement as our case, which have been
interpreted as a secondary parenchymal infiltration of
a primary leptomeningeal glioma [18]. However, this
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oma is impossible to differentiate only by radiological
changes. Thus, the literatures on PDLG are confused
with many cases that could likely represent a secondary
meningeal leptomeningeal gliomatosis [18, 19]. A nodu-
lar mass with high density was found on the surface of
right pons when we retrospectively analyzed the first
cerebral CT. The lesions were clearer in the enhanced
CT image performed at the next day of the first CT. The
above findings would rule out the possibility of paren-
chymal gliomatosis seeding into the meningeal system
through the hemorrhage. As for the hemorrhagic lesion,
the MRI showed the lesion located between the in-depth
calcarine fissure and posterior horn of lateral ventricle.
The enhanced MRI clearly revealed leptomeningeal glio-
matosis infiltrating into the hemorrhagic lesion.
The pathological features in all of PDLG patients were al-
most consistent with high-grade gliomas (WHO III or IV)
[1, 2]. In our case, the lesion showed the proliferation of
tumor cells with moderate intensity, absent of necrosis and
vascular endothelial proliferation. Tumor cells had signifi-
cant pleomorphism and atypia accompanying GFAP ex-
pression and 5 % index of Ki-67 labeling. All the findings
were consistent with the pathological features of anaplastic
astrocytoma (WHO Grade III). Saito R. et al. reported pa-
tients with leptomeningeal dissemination of anaplastic as-
trocytoma suffered from subarachnoid hemorrhage after
radiochemotherapy [20]. The hemorrhagic reasons might
be associated with vessels damage by radiochemotherapy,
or with tumor cells rupturing into pial vessels. Therefore,
our patient with PDLG presenting with intraventricular
hemorrhage that might be caused by astrocytoma cells rup-
turing into pial vessels.
This diagnosis should be differentiated from several
diseases. First of all, the tubercular meningitis should be
considered. Antituberculosis therapy had been adminis-
tered in more than half of reported cases with PDLG
[21]. Our patient had a history of tuberculosis infection,
positivity of T-SPOT examination, and aggregated le-
sions on cranial basis. However, he had no tubercular
toxic symptoms, negativity of tubercle bacillus stain, as
well as normal level of glucose and chlorine in twice
CSF examinations. All of those evidences did not sup-
port the diagnosis of tubercular meningitis. Second, the
patient presented with chronic headache, intracranial
hypertension, and lesions mainly involving pia mater,
which led to suspect the diagnosis of fungal meningitis.
There was a report of cryptococcal meningitis manifest-
ing as pseudo-subarachnoid hemorrhage [22]. However,
the glucose level was normal, India ink stain and latex
agglutination tests were negative in twice CSF examina-
tions. Third, malignant melanoma should also be consid-
ered because of its high incidence of hemorrhage in
central nervous system [23]. However, cutaneousmelanoma was not found in the patient. In addition, dif-
ferent MR sequences were not fully consistent with the
features of malignant melanoma. Fourth, meningeal car-
cinomatosis should be also taken into consideration.
However, no latent cancers were identified in the whole
body through tumor biomarker examinations, thoracic-
abdominal CT, and PET scan. Finally, cerebral vasculitis
should be distinguished. Glioblastoma mimicking as
cerebral vasculitis was reported in the literature [24].
Conclusion
In summary, we described a case of primary diffuse
leptomeningeal gliomatosis associated with anaplastic
astrocytoma. It was an interesting case of PDLG initially
presenting with intraventricular hemorrhage that might
be caused by astrocytoma rupturing into pial vessels.
Patient consent
Written informed consent was obtained from the pa-
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